BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 401823)

  • 1. Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.
    Nakagawa K; Obara T
    J Clin Endocrinol Metab; 1977 Jan; 44(1):189-93. PubMed ID: 401823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
    Candrina R
    Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of GH paradoxical responses to TRH and LHRH in acromegalic patients during long-term treatment with octreotide.
    Merola B; Colao A; Cataldi M; Rossi E; Selleri A; Briganti F; Schettini G; Bellastella A; Lombardi G
    Horm Res; 1992; 37(1-2):18-22. PubMed ID: 1398471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients.
    Yang I; Park S; Woo J; Kim S; Kim J; Kim Y; Choi Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2492-6. PubMed ID: 9253323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
    Westwood ME; Butler GE; McLellan AC; Barth JH
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
    Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
    Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
    J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.